GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Beijing Hotgen Biotech Co Ltd (SHSE:688068) » Definitions » Marketable Securities

Beijing Hotgen Biotech Co (SHSE:688068) Marketable Securities : ¥219.9 Mil (As of Mar. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Beijing Hotgen Biotech Co Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Beijing Hotgen Biotech Co's Marketable Securities for the quarter that ended in Mar. 2024 was ¥219.9 Mil.

Beijing Hotgen Biotech Co's annual Marketable Securities declined from Dec. 2021 (¥927.4 Mil) to Dec. 2022 (¥888.7 Mil) and declined from Dec. 2022 (¥888.7 Mil) to Dec. 2023 (¥280.0 Mil).


Beijing Hotgen Biotech Co Marketable Securities Historical Data

The historical data trend for Beijing Hotgen Biotech Co's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Hotgen Biotech Co Marketable Securities Chart

Beijing Hotgen Biotech Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Marketable Securities
Get a 7-Day Free Trial - - 927.45 888.69 280.02

Beijing Hotgen Biotech Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 448.56 308.16 274.34 280.02 219.87

Beijing Hotgen Biotech Co Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.


Beijing Hotgen Biotech Co  (SHSE:688068) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".


Beijing Hotgen Biotech Co Marketable Securities Related Terms

Thank you for viewing the detailed overview of Beijing Hotgen Biotech Co's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.


Beijing Hotgen Biotech Co (SHSE:688068) Business Description

Traded in Other Exchanges
N/A
Address
No. 9 Tianfu Street, 9th Building, Bio-Medical Base, Daxing District, Beijing, CHN, 102600
Beijing Hotgen Biotech Co Ltd is engaged in the development and manufacturing of innovative in-vitro diagnostic, point-of-care-testing and biodefense products.
Executives
Zhou Xin Director

Beijing Hotgen Biotech Co (SHSE:688068) Headlines

No Headlines